Key result
Angiotensin converting enzyme (ACE) inhibitors are increasingly important in antihypertensive therapy, with newer agents offering potential advantages over older ones that remain to be proven.
ACE inhibitors are effective and well-tolerated for hypertension management, though the specific advantages of newer agents over older ones remain to be proven.
Answers are grounded in this paper and cite their sources.
Reinforces ACE inhibitors as effective antihypertensives; leaves open whether newer agents offer advantages over older ones.
Angiotensin converting enzyme (ACE) inhibitors are increasingly important in antihypertensive therapy because of their efficacy, tolerability, and specific benefits in subsets of patients. They are pharmacologically diverse. Whereas most benefits have been proven with older agents (captopril, enalopril), newer agents, such as benazepril, quinapril, and ramipril, offer potential advantages that remain to be proven.
No takes yet. Share an insight, caveat, or question.
James F. Burris (1995) conducted a review in Hypertension. Angiotensin converting enzyme (ACE) inhibitors was evaluated. Angiotensin converting enzyme (ACE) inhibitors are increasingly important in antihypertensive therapy, with newer agents offering potential advantages over older ones that remain to be proven.
Synapse has enriched 10 related papers. Consider them for comparative context: